Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Vital Laboratories Pvt Ltd Plant II
483
•Vital Laboratories Pvt Ltd Plant II•September 1, 2018

Vital Laboratories Pvt Ltd Plant II – FDA 483, Sep 1, 2018

Record Details

Vital Laboratories Pvt. Ltd. received an FDA Form 483 following an inspection of their API manufacturing facility in Vapi, Gujarat, India, conducted from August 28 to September 1, 2018. The inspection identified several critical deficiencies, highlighting a lack of robust quality system controls and adherence to Good Manufacturing Practices.

Key observations included a repeat violation for incomplete batch production records, with missing signatures, dates, and essential process details. The firm also failed to thoroughly investigate and document customer complaints and unplanned deviations, frequently lacking root cause analysis and comprehensive corrective actions. A significant systemic issue was the absence of trending for common deviations, such as recurring column errors.

Further issues noted were inadequate facility controls, evidenced by the presence of food and drinks in Class D manufacturing areas, and the use of unapproved labeling on materials. Documentation practices were substandard, with unapproved scrap paper utilized for tracking pending analyses. Several Standard Operating Procedures were found to be inadequate, affecting areas like computer system user policies, incident reporting, and environmental monitoring. Additionally, the Control Sample Room exhibited temperature and humidity conditions outside specified requirements. Vital Laboratories is required to address these observations by implementing comprehensive corrective and preventative actions to ensure compliance with regulatory standards.

Company
Vital Laboratories Pvt Ltd Plant II
Inspection date
September 1, 2018
Product type
drugs
Office
Office of Inspections and Investigations
People
  • Anil B. Ghogare (Technical Director)
  • Dipesh K. Shah
View Company Profile

ID · b3e0ff39-918d-4a8b-942b-5c78f9dbc713

Other documents for Vital Laboratories Pvt Ltd Plant II
  • WARNING_LETTER - 2017-04-06April 6, 2017
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vital Laboratories Pvt Ltd Plant II
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.